Skip to main content
. 2020 Jun 8;14:154. doi: 10.3389/fncel.2020.00154

Figure 6.

Figure 6

The detrimental effect of NAFLD was abolished in ICH mice depleted of myeloid cells. (A) Flow chart illustrates drug administration and experimental design. NAFLD or control mice were given anti-Gr-1 mAb or IgG 1 day before and 1 day after ICH. Before ICH and at days1 and 3 after ICH, neurological deficits and brain water content were evaluated. (B) Results of the brain water content of mice receiving indicated treatments at day 3 after ICH. n = 10 per group. (C) Statistical data of neurological deficits assessment including mNSS test, corner-turning test, and foot-fault test score in indicated groups of mice. n = 10 per group. Data are presented as mean ± SD. *P < 0.05, **P < 0.01.